Laboratory Services

Inhibin A, Tumor Marker, Serum

Print this page

Updated Test Information:

Test Description
Inhibin A, Tumor Marker, Serum
Test ID
INHA
General Information

Useful for:



  • Aiding in the diagnosis of patients with granulosa cell tumors of the ovary when used in combination with inhibin B

  • Monitoring of patients with granulosa cell tumors and epithelial mucinous-type tumors of the ovary known to secrete inhibin A

  • For the initial evaluation of patients suspected of having a granulosa cell tumor of the ovary, order INHAB (Inhibin A and B, Tumor Marker, Serum)

Specimen Type

Serum

Specimen Requirements

  • Preferred: Red Top

  • Acceptable: Serum Gel (SST)

Stability

  • Refrigerated (preferred): 7 days

  • Frozen: 90 days

Unacceptable Specimen Conditions

Gross hemolysis

Limitations

  • Do not interpret serum inhibin levels as absolute evidence of the presence or the absence of malignant disease. Use results in conjunction with information from the clinical evaluation of the patient and other diagnostic procedures

  • Inhibin values fluctuate during the menstrual cycle. Inhibin levels in premenopausal women should be interpreted with caution

  • Some patients who have been exposed to animal antigens, either in the environment or as part of treatment or imaging procedures, may have circulating antianimal antibodies present. These antibodies may interfere with the assay reagents to produce unreliable results

  • Tumor markers are not specific for malignancy and values may vary by testing methodology. The same method should be used to serially monitor patients.

Methodology

Sequential 2-Step Immunoenzymatic Assay

Estimated TAT

1 day

Testing Schedule

Monday-Friday

Retention

12 months

CPT Code(s)

86336

Additional Information
Minimum Sample Volume

0.5 mL

Reference Range
Gender Age (years) Ref Range (pg/mL)
Male All < 2.0
Female < 11 < 4.7
11 - 17 < 97.5
Premenopausal < 97.5
Performing Lab

Mayo

LOINC Code(s)

23883-2